Skip to main content

Advertisement

Log in

Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine

  • Miscellaneous
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Antimalarial drugs such as chloroquine (CQ) and hydroxychloroquine (HCQ) are mainly used in the treatment of rheumatologic diseases, and their use may be associated with irreversible retinal toxicity. Previous studies indicate early paracentral visual field loss (Humphrey 10-2) in patients taking HCQ". These paracentral defects appear before changes in other clinical parameters as visual acuity and fundoscopy. The mechanism of CQ toxicity remains unclear. It was reported that toxic doses of CQ administered for as long as 4.5 years to Rhesus monkeys caused an initial dramatic effect on ganglion cells, followed later by photoreceptors and RPE degeneration. The purpose of this study is to explore early retinal functional changes measured by frequency-doubling technology (FDT) in patients treated with hydroxychloroquine (HCQ).

Methods

Forty-eight eyes of 48 subjects treated with hydroxychloroquine (HCQ), with no signs of retinal toxicity, and 36 eyes of 36 age and sex-matched healthy subjects were enrolled in this cross-sectional, prospective, observational, case control study. Functional testing included frequency-doubling Humphrey-matrix perimetry (FDP), white-on-white Humphrey visual field perimetry (HFA), using the 24-2 and 10-2 threshold programs, multifocal electroretinogram (mfERG, Veris 4.9) and low contrast sensitivity (CS) measurement.

Results

FDP mean deviation (MD) was found to be significantly reduced in HCQ-treated patients compared to controls both in the 24-2 (−1.38 ± 2.41 dB vs 0.21 ± 1.83dB, p < 0.01) and in the 10-2 program (−0.97 ±2.88 dB vs 0.15 ± 1.72dB, p < 0.01). FDP pattern standard deviation (PSD) was found to be significantly worse in HCQ-treated patients compared to controls both in the 24-2 (2.70 ± 0.65 dB vs 2.41 ± 0.31 dB, p < 0.01 and in the 10-2 program (2.86 ± 0.48 dB vs 2.48 ±0.39 dB, p < 0.01). HFA PSD and CS was also significantly reduced in HCQ patients, while response amplitude densities (RAD) were similar between patients and controls. A statistically significant difference in the ratio of the 5°–10° RAD and the 0°–2.5° RAD (0.31 ± 0.08 vs 0.36 ± 0.07 respectively, p < 0.05) was found between groups.

Conclusion

Frequency doubling perimetry could be useful to detect early retinal impairment in patients treated with hydroxychloroquine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rynes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36:799–805

    Article  PubMed  CAS  Google Scholar 

  2. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis (2003) The incidence of irreversible retinal toxicity in patient treated with hydroxychloroquine: a reappraisal. Ophthalmology 110:1321–1326

    Article  PubMed  Google Scholar 

  3. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T (1997) Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice. Arthritis Rheum 40:1482–1486

    Article  PubMed  CAS  Google Scholar 

  4. Tzekov R (2005) Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol 110:111–120

    Article  PubMed  Google Scholar 

  5. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF, Academy A, American Academy of Ophthalmology (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109:1377–1382

    Article  PubMed  Google Scholar 

  6. Hallberg A, Naeser P, Andersson A (1990) Effects of long-term chloroquine exposure on the phospholipids metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 68:125–130

    Article  CAS  Google Scholar 

  7. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL (1978) Choroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 17:1158–1175

    PubMed  CAS  Google Scholar 

  8. Easterbrook M (1999) Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 39:49–57

    Article  PubMed  CAS  Google Scholar 

  9. Carr RE, Gouras P, Gunkel RD (1966) Chloroquine retinopathy. Early detection by retinal threshold test. Arch Ophthalmol 75:171–178

    PubMed  CAS  Google Scholar 

  10. Pasadhika S, Fishman GA (2010) Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures. Eye (Lond) 24:340–6

    CAS  Google Scholar 

  11. Bonanomi MT, Dantas NC, Medeiros FA (2006) Retinal nerve fibre layer thickness measurements in patient using chloroquine. Clin Exp Ophthalmol 34:130–136

    Article  Google Scholar 

  12. Browning DJ (2002) Hydroxychloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol 133:649–656

    Article  PubMed  CAS  Google Scholar 

  13. Elder M, Rahman AM, McLay J (2006) Early Paracentral Visual Field Loss in Patients Taking Hydroxychloroquine. Arch Ophthalmol 124:1729–1733

    Article  PubMed  Google Scholar 

  14. Bishara SA, Matamoros N (1989) Evaluation of several tests in screening for chloroquine maculopathy. Eye 3:777–782

    PubMed  Google Scholar 

  15. Maturi RK, Yu M, Weleber RG (2004) Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122:973–981

    Article  PubMed  CAS  Google Scholar 

  16. Lai TY, Chan WM, Li H et al (2005) Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140:794-807

    Article  PubMed  Google Scholar 

  17. Johnson CA, Cioffi GA, Van Buskirk EM (1999) Frequency-doubling technology perimetry using 24-2 stimulus presentation pattern. Optom Vis Sci 76(8):571–581

    Article  PubMed  CAS  Google Scholar 

  18. Centofanti M, Fogagnolo P, Oddone F, Orzalesi N, Vetrugno M, Manni G, Rossetti L (2008) Learning effect of humphrey matrix frequency doubling technology perimetry in patients with ocular hypertension. J Glaucoma 17:436–441

    Article  PubMed  Google Scholar 

  19. Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm IH, Bird AC (1994) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1101:1522–1528

    Google Scholar 

  20. Parisi V, Perillo L, Tedeschi M, Scassa C, Gallinaro G, Capaldo N, Varano M (2007) Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration. Retina 27:879–890

    Article  PubMed  Google Scholar 

  21. Lyons JS, Severns ML (2007) Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Am J Ophthalmol 143(5):801–880

    Article  PubMed  CAS  Google Scholar 

  22. Penrose PJ, Tzekov RT, Sutter EE, Fu AD, Allen AW Jr, Fung WE, Oxford KW (2003) Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23(4):503–512

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lucia Tanga.

Additional information

The authors have no financial relationships.

The authors have full control of all primary data, and agree to allow Graefe’s Archives for Clinical and Experimantal Ophthalmology to review their data.

The authors have the full controls off all primary data and are agree to allow Graefe's Archives for clinical and Experimental Ophthamology to review our data.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanga, L., Centofanti, M., Oddone, F. et al. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. Graefes Arch Clin Exp Ophthalmol 249, 715–721 (2011). https://doi.org/10.1007/s00417-010-1612-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-010-1612-6

Keywords

Navigation